A groundbreaking cancer vaccine, OvarianVax, is currently being developed by researchers at the University of Oxford. This potential vaccine offers new hope in the fight against ovarian cancer, a disease known for its high mortality rate and silent progression. If successful, OvarianVax could prevent ovarian cancer from developing, changing the way the disease is approached… Read More »
Record Breaking Number of Bills Worth Supporting Pass in State Legislatures This Year In 2023, more vaccine related state legislation that NVIC supported has passed into law than in any other year. The COVID-19 pandemic provided an historic opportunity to inspire and encourage active citizen involvement in order to educate state legislators about the urgent… Read More »
More than 200 strains of human papillomavirus (HPV) have been identified, and about 40 of them can cause cancer, including cervical, penile, oral, vaginal, vulvar and anal cancer. Of these, cervical cancer is the most common type of HPV-related cancer in the U.S. Some strains are also responsible for genital warts.1 Ninety percent of HPV… Read More »
In a study sponsored by Yale University — and started before COVID-19 shots were rolled out — researchers tested different messages of how to best persuade people to get injected. Officially titled, “Persuasive Messages for COVID-19 Vaccine Uptake,”1 the researchers must have had some forethought that people would be wary of an experimental gene therapy,… Read More »